Divis Laboratories Ltd | DIVI - Current Liabilities

Stock Price
6,361.50
Daily Change
-17.00 -0.27%
Monthly
5.77%
Yearly
5.80%
Q2 Forecast
6,221.55

Divis Laboratories Ltd reported INR17.28B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Aurobindo Pharma INR 155.01B 8.18B Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Lupin INR 108.21B 18.59B Sep/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Tilray USD 259.32M 8.32M Sep/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025